AMG-510 |
AMG-510 : Covalent, G12C mutant specific inhibitor of KRAS
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| KRAS (Mutant:G12C) |
|
|
Covalent Inhibitor
500 nM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
Cysteine-proteome profiling
Selectivity Assessment Description:
Cysteine-proteome profiling (MS) further revealed (R)-38 to be highly selective for covalent modi ...
Potency Cellular
In Vitro
KRAS
(Mutant:G12C)
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b01180
In Vivo Validations
Mouse, Rat, Dog
Dose: 1 mg/Kg IV, 10 mg/Kg PO, Reviewer suggest 30 and 100 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
0.5 (M), 0.5 (R), 0.4 (D) h
Systemic clearance:
1.6 (M) 3.4 (R), 2.2 (D) L/h/kg
Reference: --
Negative Control Compounds
Compound-8
Chemical Information
| Molecular Formula | C30H30F2N6O3 |
| SMILEs | C=CC(=O)N1CCN(c2nc(=O)n(-c3c(C)ccnc3C(C)C)c3nc(-c4c(O)cccc4F)c(F)cc23)[C@@H](C)C1 |
| InChI | InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1 |
| Molecular weight | 560.23 Da |
| AlogP | 4.4814200000000035 |
| HBond acceptors | 9 |
| HBond donors | 1 |
| Atoms | 71 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.